header logo Pharma Manufacturing

The drug industry's voice for manufacturing excellence

  • Production
  • Development
  • Information Technology
  • Compliance
  • Quality & Risk
undefined mega-logo
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
newsletter header style 1
Feb 27, 2026Agilent’s GLP-1 CDMO business grows | Novartis plans 5th US radioligand manufacturing plant
Feb 26, 2026Charles River sells CDMO business | Big Pharma’s US investment plans short on details
Feb 25, 2026IDT Biologika looks to double sales by 2028 | AbbVie to build API plants in Chicago
Feb 24, 2026SCOTUS strikes down Trump tariffs, what’s next for pharma? | Siegfried’s 2026 outlook
Feb 21, 2026US biomanufacturing requires jumpstart in race with China | Lonza boosts advanced synthesis offering
Latest Edition|View More
footer logo Pharma Manufacturing
Helping drugmarkers leverage technology and best practices to bring new therapies to market at scale—quickly, safely and efficiently
Newsletters
The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.
Connect
Follow us for the latest industry news and insights.
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
  • About Us
  • Advertise
  • Do Not Sell or Share
  • Privacy Policy
  • Terms & Conditions
EndeavorB2B Logo
© 2026 All rights reserved.